Infectious Diseases

Pfizer announced positive data from a phase 3 trial on a bivalent RSV vaccine.

In 2022, Chile saw an influenza season with atypical timing and severity, indicating similar cases may occur in regions such as the United States.

In a simulated back-to-school trial, rate of hand-to-face contact among students wearing face masks did not differ from those without face masks, and risk of infection did not increase.

CDC, other experts are tracking increases in respiratory syncytial virus cases in infants.

At IDWeek 2022, Taylor Wells, MD, gave a presentation on how long COVID affects the pediatric population.

Deborah Molrine, MD, Clinical Program Director, QIVc at CSL Seqirus, discusses CSL Seqirus’ cell-based quadrivalent seasonal influenza vaccine, along with the effectiveness of cell-based vaccines in children.

As COVID-19 continues to spread, vaccinations remain available to protect children from severe disease, hospitalization, and death.

At the 2022 American Academy of Pediatrics National Conference & Exhibition, research was presented on which children are at high risk of severe COVID-19.

In this article, declining trends in vaccination across the United States are discussed, along with how providers can reduce vaccine hesitancy.

At the 2022 AAP National Conference & Exhibition, a professor of pediatrics describes the benefits of COVID-19 vaccines for children, safety considerations, and urges physicians to continue to urge caregivers to get their children vaccinated.

In a session at the 2022 AAP National Conference & Exhibition, a physician presenter enumerates unique challenges in treating emerging infectious diseases in children and takes a look at the current pediatric COVID-19 therapies—and evidence gaps.

At the 2022 AAP National Conference & Exhibition, one session reviews pediatric considerations for dosing, safety, and regulatory approval for medications and vaccines for SARS-CoV-2, and a look at the Pediatric Trials Network.

At the 2022 AAP National Conference & Exhibition in Anaheim, California, Rana E. El Feghaly, MD, MSCI, associate professor, University of Missouri-Kansas City, Children's Mercy Kansas City, Missouri, led a session on how pediatric clinicians can employ best practices when prescribing medications for common childhood infections.

Study links discrepancy to adults’ misbeliefs about vaccine safety.

In a recent study, severe COVID-19 made up 8% of cases among neonates aged less than 28 days.

In a recent study, investigators found that children from socioeconomically depraved families were more likely to be hospitalized from COVID-19.

Gregg Sylvester, MD, MPH, chief health officer at CSL Seqirus, discusses an FDA-approved cell-based flu vaccine for children as young as 6 months, trends in childhood vaccination rates, and how to prepare for the upcoming flu season.

Don’t click on links or attachments unless you’re sure they are legitimate.

In a recent study, pediatric patients infected with COVID-19 were more likely to develop type 1 diabetes than those infected with other respiratory illnesses.

Ian McGovern, Epidemiologist, Senior Manager at CSL Seqirus, discusses new data on influenza gathered in a recent study, and how influenza rates are expecting to rise in the 2022 to 2023 flu season.

In a recent study, researchers found that respiratory illness rates fell when precautions against COVID-19 were in place.

In a recent report, the American Academy of Pediatrics discussed how influenza affects children and how it can be prevented.

In a recent study, participants who had received a COVID-19 vaccine saw an average increase in menstrual cycle length of less than 1 day.

Hospitalized children treated with early oseltamivir (Tamiflu, Gilead Sciences) for influenza had a shorter stay and were less likely to be transferred to an intensive care unit or require other treatment.

In a recent study, it was found that access to contraceptive services declined during the COVID-19 pandemic.